Broadfoot Jill Marie
Chief Financial Officer at ATYR
- Sold, on record
- $17k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 4, 2026
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 2 of the last 8
- 2 days with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- ATYRaTYR PHARMA INCChief Financial Officer
Sales by reason
0
Routine
3
Plan not stated
3
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Feb 4, 2026No plan
Sold 4% of their holdings
$2k1,558 shares at $0.98
- Feb 4, 2025No plan
Sold 3.8% of their holdings
$5k1,254 shares at $3.78
- Feb 6, 2024No plan
Sold 7.1% of their holdings
$3k1,590 shares at $1.69
- Feb 6, 2023Plan not stated
Sold 9.2% of their holdings
$4k1,566 shares at $2.36
- Feb 9, 2021Plan not stated
Sold 3.8% of their holdings
$3k390 shares at $7.66
- Feb 7, 2020Plan not stated
Sold 5% of their holdings
$2k375 shares at $4.03
6 of 6
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Jun 24, 2026 | TLPH | Director | AwardedStock Option (Right to Buy) | 30,700 | 30,700 | SEC | ||
| Jun 22, 2026 | Jun 24, 2026 | TLPH | Director | Awarded | 5,100 | 13,647 | SEC | ||
| Feb 4, 2026 | Feb 4, 2026 | ATYR | Chief Financial Officer | Sold | 1,558 | $0.98 | $2k | 37,296 | SEC |
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 0 | SEC | ||
| Feb 3, 2026 | Feb 4, 2026 | ATYR | Chief Financial Officer | Exercised options | 3,750 | 38,854 | SEC | ||
| Jan 9, 2026 | Jan 9, 2026 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 412,500 | 412,500 | SEC | ||
| Jan 2, 2026 | Jan 6, 2026 | CUE | Director | AwardedStock Option (right to buy) | 24,400 | 24,400 | SEC | ||
| Oct 23, 2025 | Oct 24, 2025 | TLPH | Director | AwardedStock Option (Right to Buy) | 25,600 | 25,600 | SEC | ||
| Oct 23, 2025 | Oct 24, 2025 | TLPH | Director | Awarded | 4,267 | 8,547 | SEC | ||
| Jun 4, 2025 | Jun 6, 2025 | CUE | Director | AwardedStock Option (right to buy) | 48,800 | 48,800 | SEC | ||
| Feb 4, 2025 | Feb 4, 2025 | ATYR | Chief Financial Officer | Sold | 1,254 | $3.78 | $5k | 31,763 | SEC |
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 3,750 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | ATYR | Chief Financial Officer | Exercised options | 3,750 | 33,017 | SEC | ||
| Jan 8, 2025 | Jan 10, 2025 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 275,000 | 275,000 | SEC | ||
| Jun 24, 2024 | Jun 24, 2024 | TLPH | Director | AwardedStock Option (Right to Buy) | 13,044 | 13,044 | SEC | ||
| Jun 24, 2024 | Jun 24, 2024 | TLPH | Director | Awarded | 2,174 | 4,280 | SEC | ||
| May 31, 2024 | Jun 3, 2024 | ATYR | Chief Financial Officer | Bought | 5,000 | $1.79 | $9k | 27,960 | SEC |
| Feb 6, 2024 | Feb 6, 2024 | ATYR | Chief Financial Officer | Sold | 1,590 | $1.69 | $3k | 20,821 | SEC |
| Feb 5, 2024 | Feb 6, 2024 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 7,500 | SEC | ||
| Feb 5, 2024 | Feb 6, 2024 | ATYR | Chief Financial Officer | Exercised options | 3,750 | 22,411 | SEC | ||
| Jan 5, 2024 | Jan 9, 2024 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 150,000 | 150,000 | SEC | ||
| Oct 10, 2023 | Dec 13, 2023 | TLPH | Director | AwardedStock Option (Right to Buy) | 3,487 | 3,487 | SEC | ||
| Oct 10, 2023 | Dec 13, 2023 | TLPH | Director | Awarded | 581 | 2,106 | SEC | ||
| Feb 16, 2023 | Feb 21, 2023 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 84,023 | 84,023 | SEC | ||
| Feb 6, 2023 | Feb 6, 2023 | ATYR | Chief Financial Officer | Sold | 1,566 | $2.36 | $4k | 15,460 | SEC |
| Feb 3, 2023 | Feb 6, 2023 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 3,750 | 11,250 | SEC | ||
| Feb 3, 2023 | Feb 6, 2023 | ATYR | Chief Financial Officer | Exercised options | 3,750 | 17,026 | SEC | ||
| Jul 15, 2022 | Jul 15, 2022 | TLPH | Director | AwardedStock Option (Right to Buy) | 31,000 | 31,000 | SEC | ||
| Jul 15, 2022 | Jul 15, 2022 | TLPH | Director | Awarded | 15,500 | 30,500 | SEC | ||
| Jun 21, 2022 | Jun 23, 2022 | Otonomy, Inc. | Director | AwardedStock Option (right to buy) | 27,500 | 27,500 | SEC | ||
| May 24, 2022 | May 26, 2022 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 75,347 | 75,347 | SEC | ||
| Feb 3, 2022 | Feb 7, 2022 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 45,000 | 15,000 | SEC | ||
| Jan 13, 2022 | Jan 18, 2022 | ATYR | Chief Financial Officer | Bought | 1,923 | $6.75 | $13k | 12,112 | SEC |
| Nov 20, 2021 | Nov 23, 2021 | TLPH | Director | AwardedStock Option (Right to Receive) | 30,000 | 30,000 | SEC | ||
| Nov 20, 2021 | Nov 23, 2021 | TLPH | Director | Awarded | 15,000 | 15,000 | SEC | ||
| Aug 18, 2021 | Aug 20, 2021 | Otonomy, Inc. | Director | AwardedStock Option (right to buy) | 35,000 | 35,000 | SEC | ||
| May 21, 2021 | May 25, 2021 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (Right to buy) | 54,000 | 54,000 | SEC | ||
| Feb 9, 2021 | Feb 9, 2021 | ATYR | Chief Financial Officer | Sold | 390 | $7.66 | $3k | 9,833 | SEC |
| Feb 6, 2021 | Feb 9, 2021 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 892 | 0 | SEC | ||
| Feb 6, 2021 | Feb 9, 2021 | ATYR | Chief Financial Officer | Exercised options | 892 | 10,223 | SEC | ||
| Feb 4, 2021 | Feb 8, 2021 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Jun 19, 2020 | Jun 23, 2020 | ATYR | Chief Financial Officer | Bought | 1,850 | $4.22 | $8k | 9,153 | SEC |
| May 26, 2020 | May 28, 2020 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 30,000 | 30,000 | SEC | ||
| Feb 7, 2020 | Feb 7, 2020 | ATYR | Chief Financial Officer | Sold | 375 | $4.03 | $2k | 7,125 | SEC |
| Feb 6, 2020 | Feb 7, 2020 | ATYR | Chief Financial Officer | Exercised or settledRestricted Stock Unit | 893 | 893 | SEC | ||
| Feb 6, 2020 | Feb 7, 2020 | ATYR | Chief Financial Officer | Exercised options | 893 | 7,500 | SEC | ||
| Feb 5, 2020 | Feb 7, 2020 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 23,359 | 23,359 | SEC | ||
| Feb 6, 2019 | Feb 8, 2019 | ATYR | Chief Financial Officer | AwardedEmployee Stock Option (right to buy) | 75,000 | 25,000 | SEC | ||
| Sep 20, 2018 | Sep 21, 2018 | ATYR | Chief Financial Officer | Bought | 64,000 | $0.83 | $53k | 90,000 | SEC |
| Sep 14, 2018 | Sep 18, 2018 | ATYR | Chief Financial Officer | Bought | 26,000 | $0.73 | $19k | 26,000 | SEC |
Page 1
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 4, 2026 | ATYR | Chief Financial Officer | Form 4 sale | 1,558 | $2k | 4.0% | No plan | SEC |
| Feb 4, 2025 | Feb 4, 2025 | ATYR | Chief Financial Officer | Form 4 sale | 1,254 | $5k | 3.8% | No plan | SEC |
| Feb 6, 2024 | Feb 6, 2024 | ATYR | Chief Financial Officer | Form 4 sale | 1,590 | $3k | 7.1% | No plan | SEC |
| Feb 6, 2023 | Feb 6, 2023 | ATYR | Chief Financial Officer | Form 4 sale | 1,566 | $4k | 9.2% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 9, 2021 | ATYR | Chief Financial Officer | Form 4 sale | 390 | $3k | 3.8% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 7, 2020 | ATYR | Chief Financial Officer | Form 4 sale | 375 | $2k | 5.0% | Plan not stated | SEC |